Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUMINA: Mangaciclanol vs Gadobutrol for MRI of CNS or Body Lesions
NCT07472491Phase 3Recruiting
- Sponsor
- GE HealthCare
- Start
- Apr 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of mangaciclanol in Central nervous system lesion, sponsored by GE HealthCare. Started Apr 2026; status: recruiting.
02
Drugs
mangaciclanol
03
Conditions
Central nervous system lesion
Beyond the preview
Go deeper on NCT07472491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07472491.